Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Editas Medicine (EDIT) Assets Average: 2016-2025

Historic Assets Average for Editas Medicine (EDIT) over the last 10 years, with Sep 2025 value amounting to $206.2 million.

  • Editas Medicine's Assets Average fell 42.12% to $206.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $206.2 million, marking a year-over-year decrease of 42.12%. This contributed to the annual value of $420.4 million for FY2024, which is 17.04% down from last year.
  • According to the latest figures from Q3 2025, Editas Medicine's Assets Average is $206.2 million, which was down 13.05% from $237.1 million recorded in Q2 2025.
  • Editas Medicine's Assets Average's 5-year high stood at $768.1 million during Q2 2021, with a 5-year trough of $206.2 million in Q3 2025.
  • Moreover, its 3-year median value for Assets Average was $412.6 million (2024), whereas its average is $394.2 million.
  • Its Assets Average has fluctuated over the past 5 years, first surged by 38.67% in 2021, then crashed by 42.53% in 2025.
  • Over the past 5 years, Editas Medicine's Assets Average (Quarterly) stood at $697.3 million in 2021, then dropped by 25.04% to $522.7 million in 2022, then dropped by 3.97% to $501.9 million in 2023, then plummeted by 33.34% to $334.6 million in 2024, then crashed by 42.12% to $206.2 million in 2025.
  • Its Assets Average stands at $206.2 million for Q3 2025, versus $237.1 million for Q2 2025 and $302.6 million for Q1 2025.